About this trial
Long-acting injectable antiretroviral therapy (LAI ART) and Pre-Exposure Prophylaxis (LAI PrEP) have the potential to transform HIV treatment and prevention, especially in reaching individuals such as commercial minibus drivers who have minimal or no contact with traditional health facilities. The project proposes to use a culturally appropriate and community-engaged approach to promote the uptake of HIV self-testing, LAI-ART, and LAI-PrEP among commercial minibus drivers in Nigeria by engaging commercial minibus drivers as peer educators/research facilitators.
Eligibility criteria
Qualifiers
Male commercial minibus drivers who have worked as a driver for at least 6 months
18 years old or older
Currently and planning on residing in one of the LGAs during the next 12 months
Owning a mobile phone
Disqualifiers
Known HIV positivity
Not ability to provide informed consent3
No access to a cell phone
Trial design
Treatments tested in this trial
- ITEST-LAI
Treatment groups
Sponsors and collaborators
George Washington University
Lead sponsor
The George Washington University Milken Institute School of Public Health (GWU)
Collaborator